Adesto Technologies Corporation Prices Public Offering of

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
48
Adesto Technologies Corporation Prices Public Offering of Common Stock

SANTA CLARA, Calif., July 10, 2018 (GLOBE NEWSWIRE) -- Adesto Technologies (NASDAQ: IOTS ), a leading provider of innovative application-specific semiconductors for the IoT era, today announced the pricing of an underwritten public offering of 6,700,000 shares of its common stock at a public offering price of $6.00 per share.  In addition, Adesto has granted the underwriters of the offering a 30-day option to purchase up to an additional 1,005,000 shares of common stock at the public offering price, less underwriting discounts and commissions.  Adesto expects to receive net proceeds from the offering of approximately $37.3 million, after deducting the underwriting discounts and commissions and offering expenses and assuming no exercise of the underwriters’ option to purchase additional shares.  The offering is expected to close on July 13, 2018, subject to satisfaction of customary closing conditions. 

Cowen, Needham & Company, Canaccord Genuity and Roth Capital Partners are acting as joint book running managers for the offering. The Benchmark Company is acting as co-manager for the offering.

Adesto intends to use the net proceeds of the offering in part to finance its recently announced acquisition of Echelon Corporation. This offering is not contingent upon the consummation of the acquisition of Echelon Corporation. In the event that Adesto does not consummate the acquisition, Adesto intends to use the net proceeds from the offering for general corporate purposes, which may include other future acquisitions or investments in businesses, products or technologies that are complementary to Adesto.

A shelf registration statement relating to the shares of common stock offered in the public offering described above was filed with the Securities and Exchange Commission (“SEC”) on May 9, 2018 and declared effective by the SEC on June 27, 2018.  The common stock may be offered only by means of a prospectus, including a prospectus supplement, that forms a part of the effective registration statement.  A preliminary prospectus supplement and accompanying base prospectus relating to the offering has been filed with the SEC and is available on the SEC’s website at http://www.sec.gov. A copy of the final prospectus relating to the offering, when available, may be obtained from Cowen and Company, LLC, c/o Broadridge Financial Services, 1155 Long Island Avenue, Edgewood, NY 11717, Attention: Prospectus Department or by telephone at (631) 274-2806, Needham & Company, LLC, 250 Park Avenue, New York, NY 10177, Attention: Prospectus Department, by telephone at (800) 903-3268 or by email at prospectus@needhamco.com, Canaccord Genuity LLC, Attention: Equity Syndicate Department, 99 High Street, 12th Floor, Boston, Massachusetts 02110, by telephone at (617) 371-3900, or by email at prospectus@canaccordgenuity.com or Roth Capital Partners, LLC, 888 San Clemente Drive, Newport Beach, CA 92660, Attention: Prospectus Department, by telephone at (800) 678-9147 or by email at rothecm@roth.com.

This press release does not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any offer, solicitation or sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995 and other federal securities laws. Forward-looking statements can be identified by words such as: “anticipate,” “intend,” “plan,” “goal,” “seek,” “believe,” “project,” “estimate,” “expect,” “strategy,” “future,” “likely,” “may,” “should,” “will” and similar references to future periods.  Any statements contained herein which do not describe historical facts, including but not limited to statements regarding the expected net proceeds from the offering, the timing of completion of the offering, expected use of proceeds and the time frame in which the acquisition will occur are forward-looking statements that involve risks and uncertainties that could cause actual results to differ materially from those discussed in such forward- looking statements. Such risks and uncertainties include, among others, the risks identified in Adesto’s filings with the SEC, including those discussed in the section captioned “Risk Factors” contained in an exhibit to Adesto’s Current Report on Form 8-K filed with the SEC on July 9, 2018, the preliminary prospectus supplement related to the proposed public offering and subsequent filings with the SEC. Any of these risks and uncertainties could materially and adversely affect Adesto’s results of operations, which would, in turn, have a significant and adverse impact on Adesto’s stock price. Adesto cautions you not to place undue reliance on any forward-looking statements, which speak only as of the date they are made. Adesto undertakes no obligation to update publicly any forward-looking statements to reflect new information, events or circumstances after the date they were made or to reflect the occurrence of unanticipated events. Adesto Technologies Media Contact: Jen Bernier-Santarini +1 650-336-4222 press@adestotech.com

Adesto Technologies Investor Relations: Leanne K. Sievers Shelton Group 949-224-3874 sheltonir@sheltongroup.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Moore, Schulman & Moore Attorneys Earn Top Honors Again

Updated Category News Views 4

In the realm of family law, consistency in excellence matters just as much as landing a high-stakes stock trade. Moore, Schulman & Moore, APC, a San Diego family law outfit, has grabbed the spotlight yet again with nine of its ace attorneys snagging recognition from the 2027 Super Lawyers roster. A Tradition of Professional Recognition Leading the pack is Erik Moore, a...

Continue Reading
Ingram Mercantile's Aviation Push: SCORE or Sink?

Updated Category News Views 5

Unpacking Neobanx's Strategic Play Straight off the tarmac, Neobanx launches Ingram Mercantile, placing their bets on the aviation sector with none other than Eli Stepp at the helm. This ain't just another day in the sky for those in the know; it's part of a gutsy bid to inject some high-octane intelligence into the world of retail. I mean, have you seen the landscape...

Continue Reading
Zenni and Chase Stokes Foster Student Wellbeing in NYC

Updated Category News Views 3

Picture this: near 300 high schoolers milling around, glancing through shiny new glasses from the Zenni x Chase Stokes collection. In the heart of New York City, these kids are getting a double-dose of care that's all too rare—free vision screenings paired with mental health support. It's the kind of collaboration that shows you what's possible when a company, an actor,...

Continue Reading
NCICU's Digital Boost for NC Transfer Students

Updated Category News Views 4

New Platform Eases the Transfer Struggle They’ve finally cooked up something good for the college crowd in North Carolina. The NCICU, with the NCCCS, has rolled out a platform called Transfer Pathways to simplify students' path from two-year to four-year schools. This ain't just a tweak—it's backed by a hefty $2 million in grants. Hats off to those...

Continue Reading
Armor Health Strengthens Corrections Care with New Leader

Updated Category News Views 4

Fresh Blood in Correctional Healthcare Talk about stepping up where it counts! Armor Health is shaking things up, bringing in Jill Bromley as their new Regional Behavioral Health Director. The name might not ring any bells for the average Joe, but in the world of correctional healthcare, it’s like they've just upgraded from a sedan to a sports car. Armor’s game here...

Continue Reading
Helio Genomics Shakes Up Liver Cancer Detection Strategy

Updated Category News Views 5

Rethinking Liver Cancer Detection with HelioLiver Sometimes you stumble upon a tech piece that might genuinely shake up the game. Helio Genomics just poured some serious intel at the San Antonio Liver Cancer Symposium, showcasing how their HelioLiver Dx might outgun traditional scans in sniffing out hepatocellular carcinoma (HCC). They threw down four studies revealing...

Continue Reading
Elevest Unveils MADE: Shaping Wealth for Athletes, Artists

Updated Category News Views 4

Turning Talent Into Tangible Wealth Ask any musician or athlete, and they'll tell you—riding those career highs is exhilarating, but financial stability can be a different ballgame. Here comes Elevest Capital with a fresh move meant to set the players right where many falter: long-term ownership. They're rolling out MADE, a new initiative focused on flipping that burst...

Continue Reading
STRATA Showcases Excimer Laser Success in Dermatology

Updated Category News Views 4

The Cutting Edge of Skin Care: STRATA's Spotlight It's not every day you hear about dermatology shaking things up, but STRATA Skin Sciences, Inc. pulled it off with flair at the 2026 Fall Clinical Dermatology Conference in Las Vegas. For 'skin in the game,' these folks are leading the charge with their innovative excimer laser phototherapy approach, shining a fresh light...

Continue Reading
Navigating Career Growth Beyond Job Titles at Webinar

Updated Category News Views 5

Hasn't it ever struck you that job titles often fence people in like some unwanted corral, keeping potential tightly leashed? Well, here's something that might shake up your thoughts a tad. University of Phoenix is teeing up a webinar titled "Beyond The Job Title: Finding Purpose and Recognizing the Value You Bring." Scheduled for October 15, 2026, this is all about...

Continue Reading
Boliden's Q3 2026 Results: What's on the Horizon?

Updated Category News Views 3

Boliden Ready to Reveal Q3 Numbers Mark it down, folks. Thursday, October 29, 2026, is the day when Boliden's big wigs will step up to the plate and lay their cards on the table about the company's performance over the last quarter. If you've got any skin in this mining powerhouse, you'll want a front-row seat—or at least a virtual one if you're dialing in from...

Continue Reading

Top 5 Most Recently Viewed Articles

Caribou Biosciences Faces Securities Fraud Lawsuit Amid Losses

Updated Category News Views 139

Understanding the Lawsuit Against Caribou Biosciences Investors in Caribou Biosciences, Inc. (NASDAQ: CRBU) are currently facing significant challenges due to alleged misleading statements made by the company regarding its performance and product safety. A shareholder has initiated a class action lawsuit aimed at representing those who purchased CRBU securities between...

Continue Reading
BMO's Belsky Predicts Resilience of US Stocks Amid Volatility

Updated Category News Views 496

BMO's Bullish Outlook on US Stocks Brian Belsky, the Chief Investment Strategist at BMO Capital Markets, continues to maintain a positive outlook on US equities, despite the recent fluctuations in the market. His unwavering confidence comes even as the S&P 500 experiences losses in four out of the last five weeks. Belsky highlights that this downturn has been largely...

Continue Reading
How Is Pain and Suffering Calculated in Personal Injury Cases?

Updated Category Personal Finance Views 36

Pain and suffering is generally calculated by considering how an injury affects a person's physical comfort, emotional well-being, daily activities, and overall quality of life. Unlike medical bills or lost wages, these losses do not have a fixed price, so courts and insurance companies look at the nature and severity of the injury, recovery period, and long-term effects...

Continue Reading
Leap Therapeutics Showcases Financial Progress and Updates

Updated Category News Views 262

Leap Therapeutics: Financial Highlights and Updates Leap Therapeutics, Inc. (NASDAQ: LPTX), a prominent biotechnology firm dedicated to developing innovative immuno-oncology solutions, has recently revealed its financial results for the latest fiscal year. The focus today is not just on their financial performance, but also on the progress of their in-development...

Continue Reading
Tech Stocks Struggle Amid Economic Growth Concerns

Updated Category News Views 47

Current Trends Impacting Tech Stocks US tech stocks are facing significant challenges, reflecting broader worries about economic growth and the unpredictable AI market. Notably, Nvidia's shares have seen a considerable drop, highlighting the potential impacts on the technology sector. As a leading player in AI technologies, Nvidia's substantial loss in market value...

Continue Reading